Fidelity Investments’s Tevogen Inc. Common Stock TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.9K Buy
10,157
+8,119
+398% +$99.5K ﹤0.01% 4166
2025
Q4
$33.7K Sell
2,038
-82
-4% -$2.13K ﹤0.01% 4270
2025
Q3
$83.2K Sell
2,120
-19
-0.9% -$934 ﹤0.01% 3740
2025
Q2
$134K Sell
2,139
-26
-1% -$1.48K ﹤0.01% 3478
2025
Q1
$117K Sell
2,165
-99
-4% -$6.51K ﹤0.01% 3486
2024
Q4
$117K Buy
2,264
+2,071
+1,073% +$135K ﹤0.01% 3481
2024
Q3
$3.56K Buy
+193
New +$5.64K ﹤0.01% 4692

Other funds holding TVGN

Fidelity Investments's TVGN Position: Q1 2026 in Review

Fidelity Investments increased its Tevogen Inc. Common Stock (TVGN) stake by 398% in Q1 2026, buying an estimated $99.5K and bringing the position to 10,157 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4166.

Fidelity Investments first reported a position in TVGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $134K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Fidelity Investments held 10,157 shares of Tevogen Inc. Common Stock worth $45.9K as of Q1 2026.
  • Fidelity Investments bought 8,119 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $99.5K.
  • Tevogen Inc. Common Stock made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4166 holding.
  • Fidelity Investments first reported a position in Tevogen Inc. Common Stock in Q3 2024 and has held it in 7 quarters since.
  • Fidelity Investments's Tevogen Inc. Common Stock position peaked at $134K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.